Trial intelligence / Profile preview

Tibial Nerve Block vs Local Infiltration for TKA Pain

NCT03698006Completed

Sponsor
Lausanne University Hospital
Start
Feb 2021
Primary completion
Jan 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Lausanne University Hospital. Primary endpoint: Total morphine consumption at 24 hours. Started Feb 2021; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03698006.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03698006.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call